Alnylam Pharmaceuticals Net Income 2006-2020 | ALNY

Alnylam Pharmaceuticals annual/quarterly net income history and growth rate from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Alnylam Pharmaceuticals net income for the quarter ending December 31, 2020 was $-0.244B, a 11.82% decline year-over-year.
  • Alnylam Pharmaceuticals net income for the twelve months ending December 31, 2020 was $-0.858B, a 3.14% decline year-over-year.
  • Alnylam Pharmaceuticals annual net income for 2020 was $-0.858B, a 3.14% decline from 2019.
  • Alnylam Pharmaceuticals annual net income for 2019 was $-0.886B, a 16.37% increase from 2018.
  • Alnylam Pharmaceuticals annual net income for 2018 was $-0.761B, a 55.13% increase from 2017.
Alnylam Pharmaceuticals Annual Net Income
(Millions of US $)
2020 $-858
2019 $-886
2018 $-761
2017 $-491
2016 $-410
2015 $-290
2014 $-360
2013 $-89
2012 $-106
2011 $-58
2010 $-44
2009 $-48
2008 $-26
2007 $-85
2006 $-35
2005 $-43
Alnylam Pharmaceuticals Quarterly Net Income
(Millions of US $)
2020-12-31 $-244
2020-09-30 $-253
2020-06-30 $-179
2020-03-31 $-182
2019-12-31 $-276
2019-09-30 $-209
2019-06-30 $-219
2019-03-31 $-182
2018-12-31 $-211
2018-09-30 $-245
2018-06-30 $-164
2018-03-31 $-141
2017-12-31 $-142
2017-09-30 $-123
2017-06-30 $-118
2017-03-31 $-107
2016-12-31 $-113
2016-09-30 $-104
2016-06-30 $-90
2016-03-31 $-103
2015-12-31 $-91
2015-09-30 $-77
2015-06-30 $-72
2015-03-31 $-51
2014-12-31 $-21
2014-09-30 $-44
2014-06-30 $-44
2014-03-31 $-251
2013-12-31 $-32
2013-09-30 $-30
2013-06-30 $-18
2013-03-31 $-9
2012-12-31 $-62
2012-09-30 $-20
2012-06-30 $-13
2012-03-31 $-11
2011-12-31 $-14
2011-09-30 $-13
2011-06-30 $-14
2011-03-31 $-16
2010-12-31 $-7
2010-09-30 $-10
2010-06-30 $-15
2010-03-31 $-12
2009-12-31 $-8
2009-09-30 $-9
2009-06-30 $-23
2009-03-31 $-8
2008-12-31 $-9
2008-09-30 $-3
2008-06-30 $-13
2008-03-31 $-1
2007-12-31 $2
2007-09-30 $-53
2007-06-30 $-13
2007-03-31 $-22
2006-12-31 $7
2006-09-30 $-7
2006-06-30 $-10
2006-03-31 $-9
2005-12-31 $-14
2005-09-30 $-11
2005-06-30 $-11
2005-03-31 $-7
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $16.217B $0.493B
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.346B 15.00
Bristol Myers Squibb (BMY) United States $139.866B 9.72
CSL (CSLLY) Australia $91.779B 0.00
Gilead Sciences (GILD) United States $81.977B 9.18
Illumina (ILMN) United States $58.852B 89.64
Moderna (MRNA) United States $56.442B 0.00
Vertex Pharmaceuticals (VRTX) United States $55.220B 23.58
Regeneron Pharmaceuticals (REGN) United States $50.906B 16.64
Biogen (BIIB) United States $40.852B 8.17
Alexion Pharmaceuticals (ALXN) United States $34.079B 13.27
BioNTech SE (BNTX) Germany $29.499B 763.38
BeiGene (BGNE) Cayman Islands $28.269B 0.00
Seagen (SGEN) United States $25.900B 44.36
Genmab (GMAB) Denmark $22.418B 31.36
Exact Sciences (EXAS) United States $21.228B 0.00
Genmab (GNMSF) Denmark $21.156B 5.01
Horizon Therapeutics Public (HZNP) Ireland $20.498B 23.52
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.921B 0.00
Incyte (INCY) United States $17.579B 0.00
Bio-Techne Corp (TECH) United States $15.858B 90.83
Guardant Health (GH) United States $15.784B 0.00
ARGENX SE-ADR (ARGX) Netherlands $14.261B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.014B 111.70
Novavax (NVAX) United States $13.275B 0.00
Zai Lab (ZLAB) China $11.750B 0.00
QIAGEN (QGEN) Netherlands $11.693B 23.86
Repligen (RGEN) United States $11.288B 124.16
CRISPR Therapeutics AG (CRSP) Switzerland $8.730B 0.00
Mirati Therapeutics (MRTX) United States $8.616B 0.00
Acceleron Pharma (XLRN) United States $7.681B 0.00
AbCellera Biologics (ABCL) $7.640B 0.00
Fate Therapeutics (FATE) United States $7.314B 0.00
Exelixis (EXEL) United States $7.213B 66.06
Ultragenyx Pharmaceutical (RARE) United States $6.928B 0.00
Ascendis Pharma (ASND) Denmark $6.752B 0.00
Twist Bioscience (TWST) United States $6.433B 0.00
Denali Therapeutics (DNLI) United States $6.323B 201.00
Halozyme Therapeutics (HALO) United States $6.129B 47.52
NeoGenomics (NEO) United States $5.638B 688.14
Adaptive Biotechnologies (ADPT) United States $5.627B 0.00
Sarepta Therapeutics (SRPT) United States $5.602B 0.00
Vir Biotechnology (VIR) United States $5.520B 0.00
Blueprint Medicines (BPMC) United States $5.457B 17.97
Galapagos (GLPG) Belgium $5.097B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.086B 15.99
Intellia Therapeutics (NTLA) United States $4.784B 0.00
Atea Pharmaceuticals (AVIR) United States $4.675B 0.00
Beam Therapeutics (BEAM) United States $4.387B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.305B 0.00
Certara (CERT) United States $4.124B 0.00
Emergent Biosolutions (EBS) United States $4.123B 9.85
Arena Pharmaceuticals (ARNA) United States $4.000B 0.00
Legend Biotech (LEGN) United States $3.784B 0.00
I-Mab (IMAB) China $3.716B 0.00
SpringWorks Therapeutics (SWTX) United States $3.377B 0.00
Apellis Pharmaceuticals (APLS) United States $3.340B 0.00
Insmed (INSM) United States $3.274B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.263B 0.00
Reata Pharmaceuticals (RETA) United States $3.201B 0.00
Seer (SEER) $3.167B 0.00
Berkeley Lights (BLI) United States $3.131B 0.00
Arvinas (ARVN) United States $3.103B 0.00
Alkermes (ALKS) Ireland $3.029B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.022B 42.81
MorphoSys AG (MOR) Germany $2.942B 44.72
Vericel (VCEL) United States $2.663B 1155.40
Editas Medicine (EDIT) United States $2.658B 0.00
Intra-Cellular Therapies (ITCI) United States $2.564B 0.00
ALX Oncology Holdings (ALXO) United States $2.559B 0.00
Ligand Pharmaceuticals (LGND) United States $2.549B 48.25
Global Blood Therapeutics (GBT) United States $2.534B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.525B 0.00
Amicus Therapeutics (FOLD) United States $2.429B 0.00
Amarin (AMRN) Ireland $2.333B 0.00
Arcus Biosciences (RCUS) United States $2.218B 0.00
Myriad Genetics (MYGN) United States $2.118B 0.00
Sorrento Therapeutics (SRNE) United States $2.109B 0.00
PHARMA MAR SA (PHMMF) Spain $2.055B 0.00
Bionano Genomics (BNGO) United States $2.031B 0.00
Genetron Holdings (GTH) China $2.012B 0.00
Revance Therapeutics (RVNC) United States $2.008B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.991B 0.00
NGM Biopharmaceuticals (NGM) United States $1.950B 0.00
Morphic Holding (MORF) United States $1.926B 0.00
Bluebird Bio (BLUE) United States $1.891B 0.00
Seres Therapeutics (MCRB) United States $1.884B 0.00
Heska (HSKA) United States $1.843B 0.00
Inovio Pharmaceuticals (INO) United States $1.816B 0.00
Five Prime Therapeutics (FPRX) United States $1.767B 0.00
Castle Biosciences (CSTL) United States $1.736B 0.00
Cytokinetics (CYTK) United States $1.728B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.653B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.611B 0.00
Sangamo Therapeutics (SGMO) United States $1.584B 0.00
Travere Therapeutics (TVTX) United States $1.548B 0.00
Codexis (CDXS) United States $1.546B 0.00
Immunocore Holdings (IMCR) $1.530B 0.00
UniQure (QURE) Netherlands $1.518B 0.00
Kymera Therapeutics (KYMR) United States $1.499B 0.00
REGENXBIO (RGNX) United States $1.495B 0.00
Cara Therapeutics (CARA) United States $1.456B 364.88
Precigen (PGEN) United States $1.446B 0.00
Zymeworks (ZYME) Canada $1.431B 0.00
Zealand Pharma (ZEAL) Denmark $1.424B 0.00
MiMedx (MDXG) United States $1.415B 0.00
C4 Therapeutics (CCCC) United States $1.408B 0.00
Keros Therapeutics (KROS) United States $1.400B 0.00
Alector (ALEC) United States $1.382B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.322B 0.00
Ocugen (OCGN) United States $1.309B 0.00
Nurix Therapeutics (NRIX) United States $1.290B 0.00
Pliant Therapeutics (PLRX) United States $1.212B 0.00
Northwest Biotherapeutics (NWBO) United States $1.197B 0.00
Avid Bioservices (CDMO) United States $1.179B 0.00
Shattuck Labs (STTK) United States $1.179B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Protagonist Therapeutics (PTGX) United States $1.164B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.148B 0.00
Dynavax Technologies (DVAX) United States $1.140B 0.00
Repare Therapeutics (RPTX) Canada $1.138B 0.00
Mesoblast (MESO) Australia $1.104B 0.00
Mersana Therapeutics (MRSN) United States $1.092B 0.00
G1 THERAPEUTICS (GTHX) United States $1.073B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.069B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.063B 0.00
Nkarta (NKTX) United States $1.059B 0.00
MannKind (MNKD) United States $1.056B 0.00
Curis (CRIS) United States $1.052B 0.00
Scholar Rock Holding (SRRK) United States $1.026B 0.00
Coherus BioSciences (CHRS) United States $1.015B 8.25
Arcturus Therapeutics Holdings (ARCT) United States $0.972B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.923B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Prothena (PRTA) Ireland $0.911B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.892B 37.79
Adverum Biotechnologies (ADVM) United States $0.888B 0.00
Merus (MRUS) Netherlands $0.879B 0.00
Affimed (AFMD) Germany $0.860B 0.00
Cellectis S.A (CLLS) France $0.852B 0.00
Epizyme (EPZM) United States $0.852B 0.00
Pharming Group (PHAR) Netherlands $0.847B 0.00
Bolt Biotherapeutics (BOLT) United States $0.842B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.832B 0.00
Avidity Biosciences (RNA) United States $0.831B 0.00
Celldex Therapeutics (CLDX) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Adaptimmune Therapeutics (ADAP) United Kingdom $0.785B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.775B 0.00
Inhibrx (INBX) United States $0.774B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.732B 0.00
VBI Vaccines (VBIV) United States $0.716B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.714B 0.00
Starpharma Holdings (SPHRY) Australia $0.662B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.655B 0.00
Cel-Sci (CVM) United States $0.654B 0.00
Clovis Oncology (CLVS) United States $0.651B 0.00
IDEAYA Biosciences (IDYA) United States $0.641B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
ChromaDex (CDXC) United States $0.632B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.631B 0.00
DBV Technologies S.A (DBVT) France $0.631B 0.00
Kadmon Holdings (KDMN) United States $0.629B 0.00
ALBIREO PHARMA (ALBO) United States $0.628B 0.00
Adagene (ADAG) $0.627B 0.00
MeiraGTx Holdings (MGTX) United States $0.591B 0.00
Compugen (CGEN) Israel $0.576B 0.00
AnaptysBio (ANAB) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.570B 189.52
Agenus (AGEN) United States $0.570B 0.00
Inventiva S.A (IVA) France $0.558B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.539B 0.00
Forte Biosciences (FBRX) United States $0.536B 0.00
RAPT THERAPTICS (RAPT) United States $0.523B 0.00
Fortress Biotech (FBIO) United States $0.516B 0.00
AMMO (POWW) United States $0.508B 0.00
Neoleukin Therapeutics (NLTX) United States $0.507B 0.00
Amryt Pharma (AMYT) United Kingdom $0.502B 0.00
CytomX Therapeutics (CTMX) United States $0.500B 0.00
XBiotech (XBIT) United States $0.499B 0.00
AC Immune SA (ACIU) Switzerland $0.494B 0.00
Precision BioSciences (DTIL) United States $0.490B 0.00
Verastem (VSTM) United States $0.474B 0.00
Geron (GERN) United States $0.471B 0.00
Selecta Biosciences (SELB) United States $0.470B 0.00
Kala Pharmaceuticals (KALA) United States $0.466B 0.00
Angion Biomedica (ANGN) United States $0.456B 0.00
Gritstone Oncology (GRTS) United States $0.445B 0.00
AquaBounty Technologies (AQB) United States $0.444B 0.00
XOMA (XOMA) United States $0.439B 97.47
SESEN BIO, INC (SESN) United States $0.427B 0.00
Seelos Therapeutics (SEEL) United States $0.427B 0.00
Opthea (OPT) Australia $0.420B 0.00
Adicet Bio (ACET) United States $0.419B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.417B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.415B 0.00
Syros Pharmaceuticals (SYRS) United States $0.403B 0.00
UROGEN PHARMA (URGN) United States $0.401B 0.00
ANI Pharmaceuticals (ANIP) United States $0.394B 10.99
Fulcrum Therapeutics (FULC) United States $0.388B 0.00
Spero Therapeutics (SPRO) United States $0.386B 0.00
Athenex (ATNX) United States $0.383B 0.00
Athersys (ATHX) United States $0.383B 0.00
SQZ Biotechnologies (SQZ) United States $0.381B 0.00
Oncobiologics (OTLK) United States $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.376B 0.00
Cue Biopharma (CUE) United States $0.374B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.373B 0.00
Frequency Therapeutics (FREQ) United States $0.370B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.370B 0.00
CorMedix Inc (CRMD) United States $0.361B 0.00
Theratechnologies (THTX) Canada $0.358B 0.00
BioDelivery Sciences (BDSI) United States $0.358B 14.20
HOOKIPA Pharma (HOOK) United States $0.356B 0.00
Cardiff Oncology (CRDF) United States $0.348B 0.00
Bellus Health (BLU) Canada $0.343B 0.00
Codiak BioSciences (CDAK) United States $0.341B 0.00
Innate Pharma S.A (IPHA) France $0.337B 0.00
Arbutus Biopharma (ABUS) United States $0.318B 0.00
IBio (IBIO) United States $0.315B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.313B 0.00
Cogent Biosciences (COGT) United States $0.308B 0.00
WAVE Life Sciences (WVE) Singapore $0.305B 0.00
Kaleido Biosciences (KLDO) $0.300B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.293B 0.00
Trevena (TRVN) United States $0.290B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.288B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Kamada (KMDA) Israel $0.273B 15.74
NextCure (NXTC) United States $0.266B 0.00
Cerecor (CERC) United States $0.250B 0.00
OVID THERAPEUTC (OVID) United States $0.243B 0.00
Protalix BioTherapeutics (PLX) Israel $0.239B 0.00
Prima BioMed (IMMP) Australia $0.229B 0.00
Checkpoint Therapeutics (CKPT) United States $0.222B 0.00
VTv Therapeutics (VTVT) United States $0.222B 0.00
ADMA Biologics Inc (ADMA) United States $0.213B 0.00
Kindred Biosciences (KIN) United States $0.213B 0.00
OSMOTICA PHARM (OSMT) United States $0.207B 0.00
TELA Bio (TELA) United States $0.198B 0.00
LogicBio Therapeutics (LOGC) United States $0.197B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
Aptinyx (APTX) United States $0.191B 0.00
VolitionRX (VNRX) United States $0.190B 0.00
Applied Genetic Technologies (AGTC) United States $0.189B 0.00
DiaMedica Therapeutics (DMAC) United States $0.186B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.179B 5.01
Exicure (XCUR) United States $0.179B 0.00
Strongbridge Biopharma (SBBP) United States $0.178B 0.00
Antibe Therapeutics (ATBPF) Canada $0.177B 0.00
Nicox SA (NICXF) France $0.176B 0.00
INmune Bio (INMB) United States $0.176B 0.00
ObsEva SA (OBSV) Switzerland $0.175B 0.00
Chiasma (CHMA) United States $0.174B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Abeona Therapeutics (ABEO) United States $0.162B 0.00
Catalyst Biosciences (CBIO) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
X4 Pharmaceuticals (XFOR) United States $0.157B 0.00
Clearside Biomedical (CLSD) United States $0.153B 0.00
Palatin Technologies (PTN) United States $0.151B 0.00
Pluristem Therapeutics (PSTI) Israel $0.150B 0.00
Eyenovia (EYEN) United States $0.147B 0.00
Evofem Biosciences (EVFM) United States $0.145B 0.00
Erytech Pharma SA (ERYP) France $0.144B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Galena Biopharma (SLS) United States $0.136B 0.00
TRACON Pharmaceuticals (TCON) United States $0.133B 0.00
Synlogic (SYBX) United States $0.132B 0.00
Orgenesis (ORGS) United States $0.130B 266.50
Aytu BioPharma (AYTU) United States $0.129B 0.00
Novogen (KZIA) Australia $0.129B 0.00
Zosano Pharma (ZSAN) United States $0.129B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.127B 0.00
Liminal BioSciences (LMNL) Canada $0.123B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.122B 0.00
Beyond Air (XAIR) United States $0.122B 0.00
Evogene (EVGN) Israel $0.120B 0.00
Armata Pharmaceuticals (ARMP) United States $0.115B 0.00
Aptevo Therapeutics (APVO) United States $0.114B 0.00
Liquidia Technologies (LQDA) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
ARAVIVE, INC (ARAV) United States $0.108B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
Celsion (CLSN) United States $0.101B 0.00
Cocrystal Pharma (COCP) United States $0.101B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Cyclerion Therapeutics (CYCN) United States $0.097B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.095B 0.00
Lumos Pharma (LUMO) United States $0.094B 0.00
AIkido Pharma (AIKI) United States $0.092B 0.00
Cleveland BioLabs (CBLI) United States $0.090B 0.00
Vascular Biogenics (VBLT) Israel $0.083B 0.00
Advaxis (ADXS) United States $0.080B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.078B 0.00
Timber Pharmaceuticals (TMBR) United States $0.078B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
CytRx (CYTR) United States $0.077B 0.00
Purple Biotech (PPBT) Israel $0.076B 0.00
Edesa Biotech (EDSA) Canada $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Pulmatrix (PULM) United States $0.073B 0.00
ATyr Pharma (LIFE) United States $0.072B 0.00
BioCardia (BCDA) United States $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.069B 0.00
Genetic Technologies (GENE) Australia $0.069B 0.00
Organovo Holdings (ONVO) United States $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.065B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.064B 0.00
ARIDIS PHARMACT (ARDS) United States $0.063B 0.00
Windtree Therapeutics (WINT) United States $0.063B 0.00
Soligenix (SNGX) United States $0.060B 0.00
ZIVO Bioscience (ZIVO) United States $0.059B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.057B 0.00
Alimera Sciences (ALIM) United States $0.055B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
Happiness Biotech Group (HAPP) China $0.052B 0.00
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Yumanity Therapeutics (YMTX) United States $0.047B 0.00
Cyclo Therapeutics (CYTH) United States $0.046B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.045B 0.00
Vyant Bio (VYNT) United States $0.044B 0.00
Clene (CLNN) Hong Kong, SAR China $0.043B 0.00
Invo BioScience (INVO) United States $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.040B 0.59
Sonnet BioTherapeutics Holdings (SONN) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.033B 0.00
ThermoGenesis Holdings (THMO) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
Seneca Biopharma (SNCA) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Benitec Biopharma (BNTC) United States $0.024B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.010B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
China Biologic Products (CBPO) China $0.000B 29.28
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00